Salivary Fructosamine as a Noninvasive Glycemic Biomarker: A Systematic Review.

Published in: JDR clinical and translational research (2020)

Further evidence in the form of large-scale well-controlled studies is needed prior to recommending salivary fructosamine as a noninvasive diagnostic tool for glycemic status in patients with diabetes mellitus.

Keyphrases

type diabetes
glycemic control
case control
weight loss
metabolic syndrome
skeletal muscle